Steven Cohen’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.3M Buy
1,902,903
+636,224
+50% +$4.17M 0.02% 1038
2026
Q2
$7.22M Sell
1,266,679
-5,377,682
-81% -$23.2M 0.01% 1508
2026
Q1
$25.7M Sell
6,644,361
-7,079,780
-52% -$29M 0.03% 675
2025
Q4
$57.4M Buy
13,724,141
+10,983,075
+401% +$42.5M 0.06% 352
2025
Q3
$9.02M Buy
+2,741,066
New +$7.74M 0.02% 835
2023
Q2
– Sell
-30,338
Closed -$32.2K – 2639
2023
Q1
$32.2K Buy
+30,338
New +$43.7K ﹤0.01% 1882

Other funds holding PGEN

Steven Cohen's PGEN Position: Q3 2026 in Review

Steven Cohen increased its Precigen (PGEN) stake by 50% in Q3 2026, buying an estimated $4.17M and bringing the position to 1,902,903 shares worth $16.3M. The position accounts for 0.02% of the portfolio, ranked #1038.

Steven Cohen first reported a position in PGEN in Q1 2023 and has held it in 6 quarters since. The position peaked at $57.4M in Q4 2025. 244 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • Steven Cohen held 1,902,903 shares of Precigen worth $16.3M as of Q3 2026.
  • Steven Cohen bought 636,224 Precigen shares in Q3 2026, an estimated $4.17M.
  • Precigen made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1038 holding.
  • Steven Cohen first reported a position in Precigen in Q1 2023 and has held it in 6 quarters since.
  • Steven Cohen's Precigen position peaked at $57.4M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.